LD-2 disclosure · 1st Quarter - Report
GENZYME CORPORATION
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesPharmacy
Food and Drug Administration Safety and Innovation Act Implementation Biosimilars Exclusivity Period in Administration's Budget Proposal
Lobbyistsms KATHLEEN HOLCOMBE · SARA FROELICH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Agency for Healthcare Research & Quality (AHRQ) · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
FY 2013 Budget FY 2014 Budget
Lobbyistsms KATHLEEN HOLCOMBE · SARA FROELICH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Agency for Healthcare Research & Quality (AHRQ) · Centers For Medicare and Medicaid Services (CMS)
Taxation/Internal Revenue Code
Implementation of P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics Extension of R& D Tax Credit Orphan Drug Tax CreditImplementation of American Taxpayer Relief Act of 2012
Lobbyistsms KATHLEEN HOLCOMBE · SARA FROELICH
SENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Agency for Healthcare Research & Quality (AHRQ) · Centers For Medicare and Medicaid Services (CMS)
